Steal-Prone Coronary Anatomy and Myocardial Ischemia Associated With Four Primary Anesthetic Agents in Humans
- 1 January 1991
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 72 (1) , 22???27-27
- https://doi.org/10.1213/00000539-199101000-00005
Abstract
To examine the relationship between myocardial ischemia in patients with steal-prone coronary anatomy and the administration of isoflurane anesthesia, we reviewed coronary angiograms of 955 patients who had participated in a randomized trial of the use of one of four primary anesthetics for coronary artery bypass operations. Steal-prone anatomy was found in 31.8% of patients who had received enflurane; 40.0%, halothane; 32.6%, isoflurane; and 31.7%, sufentanil. Detected by ≥ 0.1 mV ST segment displacement, ischemia during anesthesia occurred in 290 (30.4%) of all patients with no difference in the incidence among the four primary anesthetics (27.5%-32.9%). Patients with steal-prone anatomy did not suffer more ischemia than patients who needed coronary artery bypass surgery but with other varieties of coronary anatomy. In patients with steal-prone coronay anatomy, the incidence of myocardial ischemia by primary anesthetic was 24.0% with enflurane, 34.4% with halothane, 32.1% with isofluvane, and 38.2% with sufentanil. Systolic blood pressure <90 mm Hg during anesthesia occurred in 416 (45.6%) patients and was twice as common during administration of volatile anesthetics than during that of sufentanil. Hypotension did not increase ischemia frequency in patients with steal-prone anatomy with use of any of the four primary anesthetics including isoflurane. Ischemia was temporally related to hypotension in only 9 patients (0.9%). In none of the 42 patients who had steal-prone anatomy and hypotension during isoflurane anesthesia was ischemia temporally related to hypotension. We conclude that myocardial ischemia is not more commonly associated with isoflurane anesthesia, even in patients with steal-prone coronary anatomy, than with any of the three other primary anesthetics evaluated. Our data do not support restrictions on use of isoflurane in patients with ischemic heart disease.Keywords
This publication has 0 references indexed in Scilit: